HCA Healthcare price target raised to $404 from $376 at RBC Capital

RBC Capital analyst Ben Hendrix raised the firm’s price target on HCA Healthcare (HCA) to $404 from $376 and keeps an Outperform rating on the shares after meeting with its management team. The firm has left the meetings incrementally more confident in HCA’s positioning for healthcare policy changes thanks to resiliency efforts, which should help soften Medicaid provisions in the Senate’s latest bill, the analyst tells investors in a research note.